Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I study of enzastaurin and bevacizumab in patients with advanced cancer: safety, efficacy and pharmacokinetics.
Nwankwo N, Zhang Z, Wang T, Collins C, Resta L, Ermisch S, Day J, Decker R, Kornberg L, Nicol S, Thornton D, Armstrong DK, Carducci MA. Nwankwo N, et al. Among authors: armstrong dk. Invest New Drugs. 2013 Jun;31(3):653-60. doi: 10.1007/s10637-012-9850-6. Epub 2012 Jul 6. Invest New Drugs. 2013. PMID: 22766773 Free PMC article. Clinical Trial.
A phase I toxicity and feasibility trial of sequential dose-dense induction chemotherapy with doxorubicin, paclitaxel, and 5-fluorouracil followed by high dose consolidation for high-risk primary breast cancer.
Emens LA, Kennedy MJ, Fetting JH, Davidson NE, Garrett E, Armstrong DK. Emens LA, et al. Among authors: armstrong dk. Breast Cancer Res Treat. 2002 Nov;76(2):145-56. doi: 10.1023/a:1020566218512. Breast Cancer Res Treat. 2002. PMID: 12452452 Clinical Trial.
Intraperitoneal cisplatin and paclitaxel in ovarian cancer.
Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA; Gynecologic Oncology Group. Armstrong DK, et al. N Engl J Med. 2006 Jan 5;354(1):34-43. doi: 10.1056/NEJMoa052985. N Engl J Med. 2006. PMID: 16394300 Free article. Clinical Trial.
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.
Rudin CM, Liu W, Desai A, Karrison T, Jiang X, Janisch L, Das S, Ramirez J, Poonkuzhali B, Schuetz E, Fackenthal DL, Chen P, Armstrong DK, Brahmer JR, Fleming GF, Vokes EE, Carducci MA, Ratain MJ. Rudin CM, et al. Among authors: armstrong dk. J Clin Oncol. 2008 Mar 1;26(7):1119-27. doi: 10.1200/JCO.2007.13.1128. J Clin Oncol. 2008. PMID: 18309947 Free PMC article.
A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: an analysis of patients enrolled in GOG 172.
Krivak TC, Tian C, Rose GS, Armstrong DK, Maxwell GL. Krivak TC, et al. Among authors: armstrong dk. Gynecol Oncol. 2009 Oct;115(1):81-85. doi: 10.1016/j.ygyno.2009.06.021. Epub 2009 Jul 12. Gynecol Oncol. 2009. PMID: 19596139 Free PMC article. Clinical Trial.
242 results